Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai
Patent
1997-04-08
1999-01-12
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ketone doai
514 23, 514 75, 514643, H61K 3112
Patent
active
058590668
ABSTRACT:
A method useful for the treatment of itching is disclosed. The method comprises applying an effective amount a 1,4-naphthoquinone to the affected area of the skin. The 1,4-naphthoquinone is hydroxy or keto at the 2 position or the 3 position, or a juglone. A composition comprising an effective amount of the 1,4-naphthoquinone, and a kit for conducting the method are also provided.
REFERENCES:
patent: 3920808 (1975-11-01), Fusaro
patent: 3974281 (1976-08-01), Gadekar
patent: 4002737 (1977-01-01), Borris
patent: 4112067 (1978-09-01), Tomalia et al.
patent: 4137301 (1979-01-01), Willer et al.
patent: 4141966 (1979-02-01), Willer et al.
patent: 4144319 (1979-03-01), Willer et al.
patent: 4160819 (1979-07-01), Willer et al.
patent: 4199575 (1980-04-01), Gunther
patent: 4259318 (1981-03-01), Duhe et al.
patent: 4344965 (1982-08-01), Stone
patent: 4428965 (1984-01-01), Elsohly et al.
patent: 4609544 (1986-09-01), Herlihy
patent: 4738956 (1988-04-01), Scott et al.
patent: 4861584 (1989-08-01), Powell, Jr. et al.
patent: 5011689 (1991-04-01), Misenko
patent: 5017361 (1991-05-01), Powell, Jr. et al.
patent: 5036050 (1991-07-01), Audhya et al.
patent: 5049580 (1991-09-01), Crouthamel
patent: 5086075 (1992-02-01), De Villez
Jones et al., "Topical Nonsteroidal Antipsoriatic Agents. 1. 1,2,3,4-Tetraoxygenated Naphthalene Derivaties.sup.1 ", J. Med. Chem, 1986, 29, 1504-1506.
Hughes et al., "Safety and Pharmacokinetics of 566C80, a Hydroxynaphthoquinone with Anti-Pneumocystis carinii Activity: A Phase I Study in Human Immunodeficiency Virus (HIV)-Infected Men", The Journal of Infectious Diseases, 1991; 163:843.
Lepoittevin et al., "Allergic contact dermatitis caused by naturally occurring quinones*", Pharmaceutisch Weekblad Scientific editions 13(3), 119-122 (1991).
Schulz et al., "The Sensitizing Capacity of Naturally Occurring Quinones*.-Experimental Studies in Guinea Pigs", Arch. Derm. Res. 258, 41-52 (1977).
Wheeler et al., "Melanin biosynthesis and the metabolism of flaviolin and 2-hydroxyjuglone in Wangiella dermatitidis", Arch. Microbiol (1985) 142:234-241.
Vietmeyer, "Science has got its hand on poson ivy, oak and sumac", Smithsonian, Aug., 1985, pp. 89-95.
Zink et al., "The effect of jewel weed in preventing poison ivy dermatitis", Journal of Wilderness Medicine 2, 178-182 (1991).
The Merck Index, Twelfth Edition, 5406.Lawsone, p. 922, 1996.
The Merck Index, Twelfth Edition, 5282.Juglone, p. 898, 1996.
Rutgers The State University of New Jersey
Schenkman Leonard
LandOfFree
Method for the treatment of itching does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of itching, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of itching will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1516580